Effects of cyclophosphamide (NSC-26271) on 127 patients with malignant lymphoma.
D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*
D003520:Cyclophosphamide